This BioCentury This Week podcast, recorded live from the BioCentury East-West Biopharma Summit in Singapore, discusses key takeaways from the event. The panel, comprised of BioCentury staff and industry executives, covers themes such as the impact of tough capital markets on the biopharma industry, the rise of the NUCO model for cross-border deals, and the increasing importance of Asian innovation hubs (particularly Japan and India). Specific examples include the launch of Calliope, a new therapeutics company spun out of Hummingbird Bioscience, and the McKinsey report highlighting potential pathways for India's biotech industry. Listeners gain insights into current trends in global biopharma investment and the evolving dynamics of the Asian biotech landscape.
